Bpifrance SA - Q1 2022 holdings

$3.57 Billion is the total value of Bpifrance SA's 8 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 11.1% .

 Value Shares↓ Weighting
STLA  STELLANTIS NV$3,165,597,000
-13.0%
192,703,9070.0%88.56%
+2.5%
CSTM  CONSTELLIUM NVcl a$295,090,000
+0.5%
16,393,9030.0%8.26%
+18.5%
CRTO  CRITEO S Aspons ads$74,059,000
-29.9%
2,718,7520.0%2.07%
-17.4%
VECT  VECTIVBIO HOLDING AG$13,217,000
-4.1%
2,806,2170.0%0.37%
+13.1%
 MIRION TECHNOLOGIES INC$10,382,000
-22.9%
1,286,4460.0%0.29%
-9.4%
SQNS  SEQUANS COMMUNICATIONS S Aspons ads$10,032,000
-35.9%
3,300,0180.0%0.28%
-24.3%
VCYT  VERACYTE INTERNATIONAL$4,198,000
-33.1%
152,2610.0%0.12%
-21.5%
CLLS  CELLECTISspons ads$1,933,000
-44.1%
425,7260.0%0.05%
-34.1%
FTI ExitTECHNIPFMC PLC$0-20,656,724
-100.0%
-2.91%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings